Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2006, Article ID 85019, 4 pages
http://dx.doi.org/10.1155/MI/2006/85019
Research Communication

Comparison of Effects of Smoking and Smokeless Tobacco “Maras Powder” Use on Humoral Immune System Parameters

1Department of Microbiology, KSU Medical School, Kahramanmaras 46050, Turkey
2Department of Public Health, KSU Medical School, Kahramanmaras 46050, Turkey
3Department of Family Medicine, KSU Medical School, Kahramanmaras 46050, Turkey

Received 26 November 2005; Revised 8 February 2006; Accepted 14 February 2006

Copyright © 2006 Murat Aral et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A Erenmemisoglu, Y Tekol, M Kartal, and S Kurucu, “The use of a smokeless tobacco in our country “Maras powder”,” in Proceedings of the 2nd International Symposium of Pharmaceutical Sciences, Ankara, Turkey, June 1991. View at Google Scholar
  2. Y Ozkul, H Donmez, A Erenmemisoglu, H Demirtas, and N Imamoglu, “Induction of micronuclei by smokeless tobacco on buccal mucosa cells of habitual users,” Mutagenesis, vol. 12, no. 4, pp. 285–287, 1997. View at Publisher · View at Google Scholar · View at PubMed
  3. M A Buyukbese, N Koksal, A Guven, and A Cetinkaya, “Effects of smokeless tobacco “Maras powder” use on respiratory functions,” The Tohoku Journal of Experimental Medicine, vol. 204, no. 3, pp. 173–178, 2004. View at Publisher · View at Google Scholar · View at PubMed
  4. P Lazarus, A M Idris, J Kim, A Calcagnotto, and D Hoffmann, “P53 mutations in head and neck squamous cell carcinomas from Sudanese snuff (toombak) users,” Cancer Detection and Prevention, vol. 20, no. 4, pp. 270–278, 1996. View at Google Scholar · View at PubMed
  5. S E Murphy, S G Carmella, A M Idris, and D Hoffmann, “Uptake and metabolism of carcinogenic levels of tobacco-specific nitrosamines by Sudanese snuff dippers,” Cancer Epidemiology, Biomarkers & Prevention, vol. 3, no. 5, pp. 423–428, 1994. View at Google Scholar · View at PubMed
  6. S N Goud, L Zhang, and A M Kaplan, “Immunostimulatory potential of smokeless tobacco extract in in vitro cultures of murine lymphoid tissues,” Immunopharmacology, vol. 25, no. 2, pp. 95–105, 1993. View at Publisher · View at Google Scholar · View at PubMed
  7. M L Sopori and W Kozak, “Immunomodulatory effects of cigarette smoke,” Journal of Neuroimmunology, vol. 83, no. 1-2, pp. 148–156, 1998. View at Publisher · View at Google Scholar · View at PubMed
  8. P G Holt, “Immune and inflammatory function in cigarette smokers,” Thorax, vol. 42, no. 4, pp. 241–249, 1987. View at Google Scholar · View at PubMed
  9. A Gulsvik and M K Fagerhoi, “Smoking and immunoglobulin levels,” Lancet, vol. 1, no. 8113, p. 449, 1979. View at Publisher · View at Google Scholar · View at PubMed
  10. D J Tollerud, J W Clark, L M Brown et al., “Association of cigarette smoking with decreased numbers of circulating natural killer cells,” The American Review of Respiratory Disease, vol. 139, no. 1, pp. 194–198, 1989. View at Google Scholar · View at PubMed
  11. D J Tollerud, J W Clark, L M Brown et al., “The effects of cigarette smoking on T cell subsets. A population-based survey of healthy caucasians,” The American Review of Respiratory Disease, vol. 139, no. 6, pp. 1446–1451, 1989. View at Google Scholar · View at PubMed
  12. C E Buckley and F C Dorsey, “Serum immunoglobulin levels throughout the life-span of healthy man,” Annals of Internal Medicine, vol. 75, no. 4, pp. 673–682, 1971. View at Google Scholar · View at PubMed
  13. D J Tollerud, J W Clark, L M Brown et al., “The influence of age, race, and gender on peripheral blood mononuclear-cell subsets in healthy nonsmokers,” Journal of Clinical Immunology, vol. 9, no. 3, pp. 214–222, 1989. View at Publisher · View at Google Scholar · View at PubMed
  14. L G Miller, G Goldstein, M Murphy, and L C Ginns, “Reversible alterations in immunoregulatory T cells in smoking. Analysis by monoclonal antibodies and flow cytometry,” Chest, vol. 82, no. 5, pp. 526–529, 1982. View at Google Scholar · View at PubMed
  15. M L Larramendy and S Knuutila, “Increased frequency of micronuclei in B and T8 lymphocytes from smokers,” Mutation Research, vol. 259, no. 2, pp. 189–195, 1991. View at Publisher · View at Google Scholar · View at PubMed
  16. R A Lindemann and N H Park, “The effects of benzo(a)pyrene, nicotine, and tobacco-specific N-nitrosamines on the generation of human lymphokine-activated killer cells,” Archives of Oral Biology, vol. 34, no. 4, pp. 283–287, 1989. View at Publisher · View at Google Scholar · View at PubMed
  17. P Moszczynski, Z Zabinski, P Jr Moszczynski, J Rutowski, S Slowinski, and Z Tabarowski, “Immunological findings in cigarette smokers,” Toxicology Letters, vol. 118, no. 3, pp. 121–127, 2001. View at Publisher · View at Google Scholar · View at PubMed
  18. J W Gerrard, D C Heiner, C G Ko, J Mink, A Meyers, and J A Dosman, “Immunoglobulin levels in smokers and non-smokers,” Annals of Allergy, vol. 44, no. 5, pp. 261–262, 1980. View at Google Scholar · View at PubMed
  19. P Andersen, O F Pedersen, B Bach, and G J Bonde, “Serum antibodies and immunoglobulins in smokers and nonsmokers,” Clinical and Experimental Immunology, vol. 47, no. 2, pp. 467–473, 1982. View at Google Scholar · View at PubMed
  20. B Burrows, M Halonen, M D Lebowitz, R J Knudson, and R A Barbee, “The relationship of serum immunoglobulin E, allergy skin tests, and smoking to respiratory disorders,” The Journal of Allergy and Clinical Immunology, vol. 70, no. 3, pp. 199–204, 1982. View at Publisher · View at Google Scholar · View at PubMed
  21. F Saitoh, M Noma, and N Sawashima, “The alkaloids contents of sixty nicotiana species,” Phytochem, vol. 24, pp. 477–480, 1985. View at Publisher · View at Google Scholar
  22. I Cok and R Ozturk, “Urinary cotinine levels of smokeless tobacco (Maras powder) users,” Human & Experimental Toxicology, vol. 19, no. 11, pp. 650–655, 2000. View at Google Scholar · View at PubMed
  23. R A Lindemann and N H Park, “Inhibition of human lymphokine-activated killer activity by smokeless tobacco (snuff) extract,” Archives of Oral Biology, vol. 33, no. 5, pp. 317–321, 1988. View at Publisher · View at Google Scholar · View at PubMed